Clinical characteristics, anti-SARS-CoV-2 IgG titers, and inflammatory markers in individuals with post-COVID-19 condition in Kenya: a cross-sectional study

Simple item page
dc.contributor.authorTheuri, Martin
dc.contributor.authorNdombi,Eric M.
dc.contributor.authorThamaini,Peris
dc.contributor.authorOgutu,James Opiyo
dc.contributor.authorOnsongo,Lister
dc.contributor.authorMadete,June K.
dc.contributor.authorOfula,Victor
dc.contributor.authorGitau,Samuel
dc.contributor.authorMwangi,Gladys
dc.contributor.authorOkemo,Paul
dc.date.accessioned2025-05-16T08:22:11Z
dc.date.available2025-05-16T08:22:11Z
dc.date.issued2024
dc.descriptionArticle
dc.description.abstractBackground: Post-coronavirus disease 2019 (post-COVID-19) is associated with considerable morbidity and reduced quality of life. However, studies characterizing the post-COVID-19 condition in Kenya are limited. This study aimed to determine the prevalence of post-COVID-19 condition and determine the clinical characteristics, anti-SARS-CoV-2 IgG titers, and concentrations of inflammatory markers of individuals with post-COVID-19 condition in Kenya. Methods: This descriptive cross-sectional study was conducted at the Kenyatta University Health Unit, Kenya. Demographic and clinical data were collected using a questionnaire. The serum levels of anti-SARS-CoV-2 antibodies, interleukin 6 (IL-6), and C-reactive protein (CRP) were quantified by enzyme-linked immunosorbent assays. Independent samples t-test was used to compare the anti-SARS-CoV-2 IgG, IL-6, and CRP levels between the participants with and without post-COVID-19 symptoms. The case definition for post-COVID-19 condition was persistence of acute COVID-19 symptoms or emergence of new symptoms 3 months after COVID19 diagnosis, symptoms lasting for ≥2 months, and absence of any other etiological basis to explain the symptoms. Results: A total of 189 volunteers were recruited in this study (median age: 21 years, range: 18–71 years; male, 49.2%). Forty participants reported having had at least one COVID-19 positive diagnosis in the past, of which 12 (30%) complained of postCOVID-19 symptoms. Significant differences in the number and duration of symptoms were observed between the individuals with and without post-COVID-19 symptoms (t-statistic = 2.87, p = 0.01; t-statistic = 2.39, p = 0.02, respectively). However, no significant differences in serum levels of anti-SARS-CoV-2 IgG, IL-6, and CRP were observed between the two groups (P = 0.08, 0.9, and 0.28, respectively).
dc.identifier.citationTheuri M, Ndombi EM, Thamaini P, Ogutu JO, Onsongo L, Madete JK, Ofula V, Gitau S, Mwangi G, Okemo P. 2024. Clinical characteristics, anti-SARS-CoV-2 IgG titers, and inflammatory markers in individuals with post-COVID-19 condition in Kenya: a cross-sectional study. PeerJ 12:e17723 DOI 10.7717/peerj.17723
dc.identifier.otherPeerJ 12:e17723 DOI 10.7717/peerj.17723
dc.identifier.urihttps://ir-library.ku.ac.ke/handle/123456789/30070
dc.language.isoen
dc.publisherPeerJ
dc.titleClinical characteristics, anti-SARS-CoV-2 IgG titers, and inflammatory markers in individuals with post-COVID-19 condition in Kenya: a cross-sectional study
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Full text research article.pdf
Size:
1.65 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.66 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
RP-Deparment of Medical Laboratory Sciences